Generation of αGal-enhanced bifunctional tumor vaccine
Jian He(Theranostics (New Zealand)), Liping Zhong(Guangxi Medical University), Yiqun Luo(Theranostics (New Zealand)), Yu Huo(Xiamen Chang Gung Hospital), Huixue Wang(The University of Texas MD Anderson Cancer Center), Wei Shi(Guangxi University), Lan Li, Bing Wang(Central South University), Xiuli Liu(Guangxi Medical University), Lu Gan(University of Science and Technology of China), Zhikun Zhang(Theranostics (New Zealand)), Yong Huang(Guangxi Medical University), Pan Wu(Theranostics (New Zealand)), Xiyu Liu(Guangxi Medical University), Tao Wu(The First People's Hospital of Changde), Chao Tang(Guiyang Medical University), Yongxiang Zhao(Guangxi Medical University), Qiaoying Chen(Guangxi Medical University)
Cited by 7
Related Papers
Engineering a precise adenine base editor with minimal bystander editing
|Nature Chemical Biology|2022|183
Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990–2019: results from a global burden of disease study, 2019
|BMC Public Health|2022|177
Database Resources of the BIG Data Center in 2018
|Nucleic Acids Research|2017|159
Ambient high temperature exposure and global disease burden during 1990–2019: An analysis of the Global Burden of Disease Study 2019
|The Science of The Total Environment|2021|85
Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
|Cell Death and Disease|2020|80